American Biogenetic regulatory update

MAXBA (Notre Dame, Ind.) received U.S. Patent No. 5,294,548 covering a recombinant vaccine for hepatitis A. Medeva PLC has a two-year option to acquire a worldwide license for the vaccine. The option ...